未登录 Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysis 肿瘤和淋巴结分期对III期结直肠癌患者辅助奥沙利铂为基础化疗疗效的影响：一项ACCENT合并分析 Cohen, R.; Raeisi, M.; Chibaudel, B.; Yothers, G.; Goldberg, R. M.; Bachet, J. -B; Wolmark, N.; Yoshino, T.; Schmoll, H. -J; Haller, D. G.; Kerr, R.; Lonardi, S.; George, T. J.; Shacham-Shmueli, E.; Shi, Q.; Andre, T.; de Gramont, A. 分享 收藏
Chronologic improvement in survival of first-line oxaliplatin based chemotherapy plus targeted therapy for metastatic colorectal cancer (mCRC): Analysis of the ARCAD database Takeda, Y.; Yamazaki, K.; Saltz, L.; Douillard, J-Y.; Punt, C. J. A.; Van Cutsem, E.; Bokemeyer, C.; Venook, A.; Koopman, M.; Heinemann, V.; Cremolini, C.; Hecht, J. R.; Schmoll, H. J. E-V.; Nakayama, G.; Sugihara, K.; Oki, E.; Andre, T.; Shi, Q.; De Gramont, A.; Yoshino, T. 分享 收藏
Efficacy of immune checkpoint inhibitors for metastatic colorectal cancer with microsatellite instability in second or latter line using synthetic control arms: A non-randomised evaluation Cohen, Romain; Raeisi, Morteza; Chibaudel, Benoist; Yoshino, Takayuki; Shi, Qian; Zalcberg, John R.; Adams, Richard; Cremolini, Chiara; Grothey, Axel; Mayer, Robert J.; Van Cutsem, Eric; Tabernero, Josep; Bando, Hideaki; Misumi, Toshihiro; Overman, Michael J.; Andre, Thierry; de Gramont, Aimery 分享 收藏
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database Karapetis, C. S.; Liu, H.; Sorich, M. J.; Pederson, L. D.; Van Cutsem, E.; Maughan, T.; Douillard, J. Y.; O'Callaghan, C. J.; Jonker, D.; Bokemeyer, C.; Sobrero, A.; Cremolini, C.; Chibaudel, B.; Zalcberg, J.; Adams, R.; Buyse, M.; Peeters, M.; Yoshino, T.; de Gramont, A.; Shi, Q. 分享 收藏
NUC-3373 in combination with irinotecan (NUFIRI) or oxaliplatin (NUFOX) and bevacizumab for second-line treatment of patients with advanced colorectal cancer (NuTide:302) Khan, Khurum; Mukherjee, Uma; Schlechter, Benjamin L.; Ciombor, Kristen K.; Skolariki, Aglaia; Coveler, Andrew L.; Graham, Janet S.; Peters, Mary Linton; Cohen, Stacey A.; Mettu, Niharika; Marijon, Helene; Cosgrove, David; McKissock, Fiona G.; Oelmann, Elisabeth; Bloss, Jeffrey D.; Blagden, Sarah P.; de Gramont, Aimery; Berlin, Jordan; Evans, T. R. Jeffry 分享 收藏
Phase II study of NUC-3373, leucovorin, irinotecan (NUFIRI) plus bevacizumab vs FOLFIRI plus bevacizumab for the second-line treatment of patients with advanced/metastatic colorectal cancer (NuTide:323) Wilson, Richard H.; Ciombor, Kristen K.; Coveler, Andrew L.; Graham, Janet S.; Schlechter, Benjamin L.; George, Thomas J.; Elez, Elena; Evans, T. R. Jeffry; Berlin, Jordan; de Gramont, Aimery; McKissock, Fiona G.; Oelmann, Elisabeth; Bloss, Jeffrey D.; Martini, Giulia; Bennouna, Jaafar; Modest, Dominik P.; Taieb, Julien; Tabernero, Josep 分享 收藏
Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database (vol 178, pg 162, 2023) Margalit, Ofer; Harmsen, William S.; Shacham-Shmueli, Einat; Voss, Molly M.; Boursi, Ben; Wagner, Anna D.; Cohen, Romain; Olswold, Curtis L.; Saltz, Leonard B.; Goldstein, Daniel A.; Hurwitz, Herbert; Tebbutt, Niall C.; Kabbinavar, Fairooz F.; Adams, Richard A.; Chibaudel, Benoist; Grothey, Axel; Yoshino, Takayuki; Zalcberg, John; de Gramont, Aimery; Shi, Qian; Lenz, Heinz-Josef 分享 收藏
分享 收藏
Phase III study of NUC-1031+cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121) Knox, J.; Bazin, I.; Oh, D.; Zubkov, O.; Breder, V.; Bai, L.; Christie, A.; McNamara, M.; Goyal, L.; Cosgrove, D.; Springfeld, C.; Sjoquist, K.; Park, J.; Verdaguer, H.; Braconi, C.; Ross, P.; de Gramont, A.; Shroff, R.; Zalcberg, J.; Palmer, D.; Valle, J. 分享 收藏
Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer 生物标志物驱动的转移性结直肠癌维持治疗MODUL试验 (队列1、3和4) 的临床和探索性生物标志物发现 Ducreux, Michel; Tabernero, Josep; Grothey, Axel; Arnold, Dirk; O'Dwyer, Peter J.; Gilberg, Frank; Abbas, Alexander; Das Thakur, Meghna; Prizant, Hen; Irahara, Natsumi; Tahiri, Anila; Schmoll, Hans -Joachim; Van Cutsem, Eric; de Gramont, Aimery 分享 收藏
Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database Margalit, Ofer; Harmsen, William S.; Shacham-Shmueli, Einat; Voss, Molly M.; Boursi, Ben; Wagner, Anna D.; Cohen, Romain; Olswold, Curtis L.; Saltz, Leonard B.; Goldstein, Daniel A.; Hurwitz, Herbert; Tebbutt, Niall C.; Kabbinavar, Fairooz F.; Adams, Richard A.; Chibaudel, Benoist; Grothey, Axel; Yoshino, Takayuki; Zalcberg, John; de Gramont, Aimery; Shi, Qian; Lenz, Heinz-Josef 分享 收藏
Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database Franko, Jan; Yin, Jun; Adams, Richard A.; Zalcberg, John; Fiskum, Jack; Van Cutsem, Eric; Goldberg, Richard M.; Hurwitz, Herbert; Bokemeyer, Carsten; Kabbinavar, Fairooz; Curtis, Alexandra; Meyers, Jeffery; Chibaudel, Benoist; Yoshino, Takayuki; de Gramont, Aimery; Shi, Qian 分享 收藏
MODUL cohort 2: an adaptable, randomized, signal-seeking trial of fluoropyrimidine plus bevacizumab with or without atezolizumab maintenance therapy for BRAFwt metastatic colorectal cancer Tabernero, J.; Grothey, A.; Arnold, D.; de Gramont, A.; Ducreux, M.; O'Dwyer, P.; Tahiri, A.; Gilberg, F.; Irahara, N.; Schmoll, H-J; Van Cutsem, E. 分享 收藏
Impact of age on treatment strategies in RAS/BRAF wildtype metastatic colorectal cancer (mCRC): A prespecified subgroup analysis of the GERCOR-PRODIGE STRATEGIC-1 phase III study Carola, E.; Chibaudel, B.; Boulahssass, R.; Dourthe, L. M.; Andre, T.; Henriques, J.; Bourgeois, V.; Etienne, P-L.; Desrame, J.; Dupuis, O.; Baba-Hamed, N.; Auby, D.; Louvet, C.; Maillard, E.; Tournigand, C.; Garcia-Larnicol, M-L.; Shmueli, E. Shacham; Bird, B. H.; Ghiringhelli, F.; De Gramont, A. 分享 收藏
NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302) Coveler, A.; Skolariki, A.; Ciombor, K. K.; Jourdier, H. Marijon; Graham, J.; Peters, M. L.; Cohen, S. A.; Myers, M.; Oelmann, E. M.; Bloss, J.; Blagden, S. P.; De Gramont, A.; Berlin, J. D.; Evans, T. R. J. 分享 收藏
Clinical classification-based evaluation of adjuvant therapy with oxaliplatin in stage II colon cancer Chibaudel, B.; Raeisi, M.; Andre, T.; Yothers, G.; Schmoll, H.; Bachet, J.; Cohen, R.; Wolmark, N.; Yoshino, T.; Goldberg, R.; Kerr, R.; Lonardi, S.; George, T.; Shacham-Shmueli, E.; Sharara, L.; Shi, Q.; de Gramont, A. 分享 收藏
Evaluating sex as a predictive marker for response to bevacizuamb in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database Margalit, O.; Harmsen, W.; Shacham-Shmueli, E.; Voss, M.; Boursi, B.; Cohen, R.; Olswold, C.; Saltz, L.; Hurwitz, H.; Adams, R.; Chibaudel, B.; Grothey, A.; Yoshino, T.; Zalcberg, J.; de Gramont, A.; Shi, Q.; Lenz, H. 分享 收藏
Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer=70 years Papamichael, Demetris; Lopes, Guilherme S.; Olswold, Curt L.; Douillard, Jean-Yves; Adams, Richard A.; Maughan, Timothy S.; Van Cutsem, Eric; Venook, Alan P.; Lenz, Heinz-Josef; Heinemann, Volker; Kaplan, Richard; Bokemeyer, Carsten; Chibaudel, Benoist; Grothey, Axel; Yoshino, Takayuki; Zalcberg, John; De Gramont, Aimery; Shi, Qian 分享 收藏
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology 转移性癌症的临床试验终点: 使用个体参与者数据为未来的试验方法提供信息 Goldberg, Richard M.; Adams, Richard; Buyse, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; Burzykowski, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C.; Zalcberg, John; Tabernero, Josep; Van Cutsem, Eric; Matheson, Alastair; de Gramont, Aimery 分享 收藏
A phase Ib study of NUC-3373, a targeted inhibitor of thymidylate synthase, in combination with standard therapies in patients with advanced colorectal cancer (NuTide:302) Berlin, J.; Coveler, A. L.; Ciombor, K. K.; Kazmi, F.; Graham, J.; Peters, M. L.; Clark, J. W.; Myers, M.; De Gramont, A.; Evans, T. R. J.; Blagden, S. 分享 收藏
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
